Vivani Medical Net Worth
Vivani Medical Net Worth Breakdown | VANI |
Vivani Medical Net Worth Analysis
Vivani Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Vivani Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Vivani Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Vivani Medical's net worth analysis. One common approach is to calculate Vivani Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Vivani Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Vivani Medical's net worth. This approach calculates the present value of Vivani Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Vivani Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Vivani Medical's net worth. This involves comparing Vivani Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Vivani Medical's net worth relative to its peers.
Enterprise Value |
|
To determine if Vivani Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Vivani Medical's net worth research are outlined below:
| Vivani Medical may become a speculative penny stock | |
| Vivani Medical has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (25.65 M) with profit before overhead, payroll, taxes, and interest of 130 K. | |
| Vivani Medical currently holds about 3.45 M in cash with (23.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28. | |
| Vivani Medical has a poor financial position based on the latest SEC disclosures | |
| Roughly 45.0% of the company outstanding shares are owned by insiders | |
| Latest headline from huffpost.com: I Have Chronically Dry Eyes And This Is The 29 Product That My Doctor Recommended |
Vivani Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Vivani Medical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Vivani Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Know Vivani Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Vivani Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vivani Medical backward and forwards among themselves. Vivani Medical's institutional investor refers to the entity that pools money to purchase Vivani Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Charles Schwab Investment Management Inc | 2024-06-30 | 30 K | Two Sigma Securities, Llc | 2024-06-30 | 25.7 K | Group One Trading, Lp | 2024-06-30 | 14.4 K | Tower Research Capital Llc | 2024-06-30 | 13.4 K | Ground Swell Capital, Llc | 2024-06-30 | 12.6 K | Susquehanna International Group, Llp | 2024-06-30 | 10.3 K | Goss Wealth Management Llc | 2024-06-30 | 1.4 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.1 K | Royal Bank Of Canada | 2024-06-30 | 490 | Sabby Management Llc | 2024-06-30 | 2.1 M | Tanager Wealth Management Llp | 2024-09-30 | 1.3 M |
Follow Vivani Medical's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 69.62 M.Market Cap |
|
Project Vivani Medical's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.56) | (0.59) | |
| Return On Capital Employed | (0.67) | (0.71) | |
| Return On Assets | (0.56) | (0.59) | |
| Return On Equity | (1.24) | (1.30) |
When accessing Vivani Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Vivani Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Vivani Medical's profitability and make more informed investment decisions.
Evaluate Vivani Medical's management efficiency
Vivani Medical has return on total asset (ROA) of (0.2929) % which means that it has lost $0.2929 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.861) %, meaning that it created substantial loss on money invested by shareholders. Vivani Medical's management efficiency ratios could be used to measure how well Vivani Medical manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.59. The current Return On Capital Employed is estimated to decrease to -0.71. As of now, Vivani Medical's Debt To Assets are decreasing as compared to previous years. The Vivani Medical's current Asset Turnover is estimated to increase to 0.23, while Total Assets are projected to decrease to under 23.7 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.41 | 0.39 | |
| Tangible Book Value Per Share | 0.41 | 0.39 | |
| Enterprise Value Over EBITDA | (1.95) | (2.05) | |
| Price Book Value Ratio | 2.50 | 2.62 | |
| Enterprise Value Multiple | (1.95) | (2.05) | |
| Price Fair Value | 2.50 | 2.62 | |
| Enterprise Value | -13.4 M | -12.7 M |
Leadership effectiveness at Vivani Medical is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Return On Equity (0.86) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vivani Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vivani Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Vivani Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Vivani Medical time-series forecasting models is one of many Vivani Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Vivani Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Vivani Medical Earnings per Share Projection vs Actual
Vivani Medical Corporate Management
| Brigid Makes | Chief Officer | Profile | |
| Adam Mendelsohn | Chairman CoFounder | Profile | |
| Truc MBA | Chief Officer | Profile | |
| Donald MBA | Chief Secretary | Profile | |
| Lisa MD | Chief Officer | Profile | |
| Kayte Fischer | CoFounder | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vivani Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Vivani Stock please use our How to Invest in Vivani Medical guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vivani Medical. If investors know Vivani will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vivani Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Return On Assets (0.29) | Return On Equity (0.86) |
The market value of Vivani Medical is measured differently than its book value, which is the value of Vivani that is recorded on the company's balance sheet. Investors also form their own opinion of Vivani Medical's value that differs from its market value or its book value, called intrinsic value, which is Vivani Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivani Medical's market value can be influenced by many factors that don't directly affect Vivani Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vivani Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivani Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivani Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.